Extraordinary collateral mutagenesis induced by CX-5461
Crossref DOI link: https://doi.org/10.1038/s41588-023-01611-8
Published Online: 2023-12-21
Published Print: 2024-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boulton, Simon J. http://orcid.org/0000-0001-6936-6834
Text and Data Mining valid from 2023-12-21
Version of Record valid from 2023-12-21
Article History
First Online: 21 December 2023
Competing interests
: S.J.B. is a co-founder, vice-president of science strategy and a shareholder of Artios Pharma.